Influence of N-Linked Glycans in V4-V5 Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp160 on Induction of a Virus-Neutralizing Humoral Response
- 1 July 1996
- journal article
- basic science
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 12 (3), 213-220
- https://doi.org/10.1097/00042560-199607000-00001
Abstract
Summary: One of the functions of N-linked glycans of viral glycoproteins is protecting otherwise accessible neutralization epitopes of the viral envelope from neutralizing antibodies. The aim of the present study was to explore the possibility to obtain a more broadly neutralizing immune response by immunizing guinea pigs with gp160 depleted of three N-linked glycans in the CD4-binding domain by site-directed mutagenesis. Mutant and wild type gp160 were formulated into immunostimulating complexes and injected s.c. into guinea pigs. Both preparations induced high serum antibody response to native gp120 and V3 peptides. Both preparations also induced antibodies that bound equally well to the V3 loop or the CD4-binding region, as determined by a competitive enzyme-linked immunosorbent assay (ELISA). The sera from animals, immunized with mutated glycoprotein, did not neutralize nonrelated HIV strains better than did sera from animals, immunized with wild type glycoprotein. Instead, a pattern of preferred homologous neutralization was observed, i.e., sera from animals, immunized with mutant gp160, neutralized mutant virus better than wild type virus, and vice versa. These data indicated that elimination of the three N-linked glycans from gp160 resulted in an altered local antigenic conformation but did not uncover hidden neutralization epitopes, broadening the immune response.Keywords
This publication has 43 references indexed in Scilit:
- Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4Archiv für die gesamte Virusforschung, 1994
- Identification of three N-linked glycans in the V4–V5 region of HIV-1 gp 120, dispensable for CD4-binding and fusion activity of gp 120Archiv für die gesamte Virusforschung, 1994
- Neutralization of HIV-1AIDS Research and Human Retroviruses, 1994
- Further characterization of an antigenic site of HIV-I gp120 recognized by virus neutralizing human monoclonal anti bodiesAIDS, 1993
- Carbohydrate-induced conformational changes strongly modulate the antigenicity of coronavirus TGEV glycoproteins S and MVirus Research, 1991
- Effects of mutations in glycosylation sites and disulphide bonds on processing, CD4-binding and fusion activity of human immunodeficiency virus envelope glycoproteinsJournal of General Virology, 1991
- Activity of herpes simplex virus type 1-specified glycoprotein C antigenic site II epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharidesJournal of General Virology, 1990
- Cystein 402 of HIV gp120 is essential for CD4-binding and resistance of gp120 to intracellular degradationArchiv für die gesamte Virusforschung, 1989
- A strategy simplifying site-directed mutagenesis in the CD4-binding region of HIV gp 120Archiv für die gesamte Virusforschung, 1989
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985